Li Chun Han

StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA.

Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts.

Part of Uni-President Enterprises Corp., President Futures Corp. is a financial company based in Taipei, Taiwan. The Taiwanese company specializes in providing investors with a tool to hedge against interest rate risks and to capitalize on potential profits from interest rate changes through the use of financial derivatives, specifically the US Treasury bond futures. The company offers a comprehensive guide on the basic concepts, operational principles, and factors affecting the price of US Treasury bond futures. The guide also includes information on the types of US Treasury bonds, the contract specifications of US Treasury bond futures, and how to calculate profits and losses. The company's services are mainly targeted towards institutional investors who hold large amounts of bonds and require flexible trading options.